Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, Reduced, 2023 Q4

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Reduced

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q4 2023: Stock VERONA PHARMA PLC; Country of operation —; Class SPONSORED ADS; Shares before 176,483.
  • Q4 2023: Stock EMEREN GROUP LTD; Country of operation —; Class SPONSORED ADS; Shares before 366,043.
  • Q4 2023: Stock TDCX INC; Country of operation —; Class ADS; Shares before 140,920.
  • Q4 2023: Stock ALMACENES EXITO S A; Country of operation —; Class SPON ADS; Shares before 108,367.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2023VERONA PHARMA PLC
CUSIP 925050106
—SPONSORED ADS176,48328,190-148,293$2,876,673$560,417-$2,316,2562024-02-14
Q4 2023EMEREN GROUP LTD
CUSIP 75971T301
—SPONSORED ADS366,043252,552-113,491$1,127,412$689,467-$437,9452024-02-14
Q4 2023TDCX INC
CUSIP 87190U100
—ADS140,92096,797-44,123$832,837$469,466-$363,3712024-02-14
Q4 2023ALMACENES EXITO S A
CUSIP 02028M105
—SPON ADS108,36749,849-58,518$593,851$357,417-$236,4342024-02-14
Q4 2023NATURA &CO HLDG S A
CUSIP 63884N108
—ADS52,86010,344-42,516$305,002$70,753-$234,2492024-02-14
Q4 2023EDAP TMS S A
CUSIP 268311107
FranceSPONSORED ADR50,76024,777-25,983$356,335$130,823-$225,5122024-02-14
Q4 2023COMPANHIA PARANAENSE DE ENER
CUSIP 20441B605
—SPON ADS31,3826,045-25,337$275,220$51,262-$223,9582024-02-14
Q4 2023JAMES HARDIE INDS PLC
CUSIP 47030M106
—SPONSORED ADR50,84139,746-11,095$1,334,068$1,536,978+$202,9102024-02-14
Q4 2023MORPHOSYS AG
CUSIP 617760202
—SPONSORED ADS133,28098,198-35,082$895,642$972,160+$76,5182024-02-14
Q4 2023ADAPTIMMUNE THERAPEUTICS PLC
CUSIP 00653A107
—SPONDS ADR3,549,5593,399,514-150,045$2,768,656$2,695,815-$72,8412024-02-14
Q4 2023BIOLINERX LTD
CUSIP 09071M205
—SPONSORED ADS58,95424,215-34,739$107,296$38,018-$69,2782024-02-14
Q4 2023CALLIDITAS THERAPEUTICS AB
CUSIP 13124Q106
—SPONSERED ADS4,958827-4,131$90,533$21,312-$69,2212024-02-14
Q4 2023HYWIN HLDG LTD
CUSIP 44951X104
—ADS12,36510,752-1,613$88,410$19,891-$68,5192024-02-14
Q4 2023COSAN S A
CUSIP 22113B103
BrazilADS97,53988,751-8,788$1,325,555$1,389,841+$64,2862024-02-14
Q4 2023SO YOUNG INTERNATIONAL INC
CUSIP 83356Q108
Cayman IslandsSPONSORED ADS131,03860,743-70,295$134,969$76,536-$58,4332024-02-14
Q4 2023ZEPP HEALTH CORPORATION
CUSIP 98945L105
—SPONSORED ADS123,15872,723-50,435$141,632$103,267-$38,3652024-02-14
Q4 2023PHOENIX NEW MEDIA LTD
CUSIP 71910C202
—SPONSORED ADS59,52227,778-31,744$74,998$37,778-$37,2202024-02-14
Q4 2023HUIZE HLDG LTD
CUSIP 44473E105
—SPONSORED ADS33,33611,857-21,479$36,670$10,671-$25,9992024-02-14
Q4 2023CANGO INC
CUSIP 137586103
—ADS30,43919,537-10,902$36,101$19,928-$16,1732024-02-14
Q4 2023MIX TELEMATICS LTD
CUSIP 60688N102
—SPONSORED ADR18,63411,007-7,627$102,860$94,770-$8,0902024-02-14
Q4 2023PURPLE BIOTECH LTD
CUSIP 74638P109
—SPONSORED ADS13,92511,777-2,148$16,014$9,186-$6,8282024-02-14
Q4 2023LIXIANG ED HLDG CO LTD
CUSIP 53934A115
—SPON ADS107,45029,919-77,531$29,441$32,313+$2,8722024-02-14
Q4 2023VIOMI TECHNOLOGY CO LTD
CUSIP 92762J103
Cayman IslandsSPONSORED ADS20,09119,611-480$20,292$19,611-$6812024-02-14
Q4 2023GRUPO AVAL ACCIONES Y VALORE
CUSIP 40053W101
ColombiaSPONSORED ADS27,46427,117-347$66,463$65,894-$5692024-02-14